06 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ash-2024--studies-of-olverembatinib-selected-for-presentations-including-an-oral-report-for-the-seventh-consecutive-year-302297311.html
13 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/live-from-esmo-2024--ascentage-pharma-releases-latest-data-showing-sustained-clinical-efficacy-of-olverembatinib-in-sdh-deficient-gist-during-a-mini-oral-presentation-302248193.html
07 Jul 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/olverembatinib-approved-for-commercialization-in-macau-china-302190451.html
03 Jul 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ascentage-pharma-received-us100-million-option-payment-from-takeda-302189330.html
18 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/live-from-eha-2024--posters-featuring-results-from-three-studies-of-olverembatinib-including-encouraging-data-from-us-study-in-cml-and-ph-all-302175024.html
14 Jun 2024
// BUSINESSWIRE
LOOKING FOR A SUPPLIER?